BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 19709639)

  • 1. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
    Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
    J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
    Nornoo AO; Zheng H; Lopes LB; Johnson-Restrepo B; Kannan K; Reed R
    Eur J Pharm Biopharm; 2009 Feb; 71(2):310-7. PubMed ID: 18793723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of fenofibrate microemulsion for improved bioavailability.
    Hu L; Wu H; Niu F; Yan C; Yang X; Jia Y
    Int J Pharm; 2011 Nov; 420(2):251-5. PubMed ID: 21907776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme.
    Cheng MB; Wang JC; Li YH; Liu XY; Zhang X; Chen DW; Zhou SF; Zhang Q
    J Control Release; 2008 Jul; 129(1):41-8. PubMed ID: 18474405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of udenafil-loaded microemulsions for intranasal delivery: in vitro and in vivo evaluations.
    Cho HJ; Ku WS; Termsarasab U; Yoon I; Chung CW; Moon HT; Kim DD
    Int J Pharm; 2012 Feb; 423(2):153-60. PubMed ID: 22209996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid.
    Xi J; Chang Q; Chan CK; Meng ZY; Wang GN; Sun JB; Wang YT; Tong HH; Zheng Y
    AAPS PharmSciTech; 2009; 10(1):172-82. PubMed ID: 19224372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing surfactant content to improve oral bioavailability of ibuprofen in microemulsions: just enough or more than enough?
    You X; Xing Q; Tuo J; Song W; Zeng Y; Hu H
    Int J Pharm; 2014 Aug; 471(1-2):276-84. PubMed ID: 24858390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.
    Djekic L; Primorac M
    Int J Pharm; 2008 Mar; 352(1-2):231-9. PubMed ID: 18068919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
    Balakrishnan P; Lee BJ; Oh DH; Kim JO; Lee YI; Kim DD; Jee JP; Lee YB; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2009 Jun; 374(1-2):66-72. PubMed ID: 19446761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evaluation of a novel oral delivery system for rhPTH1-34: in vitro and in vivo.
    Guo L; Ma E; Zhao H; Long Y; Zheng C; Duan M
    Int J Pharm; 2011 Nov; 420(1):172-9. PubMed ID: 21888960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin.
    Zhang P; Liu Y; Feng N; Xu J
    Int J Pharm; 2008 May; 355(1-2):269-76. PubMed ID: 18242895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.
    Cuiné JF; Charman WN; Pouton CW; Edwards GA; Porter CJ
    Pharm Res; 2007 Apr; 24(4):748-57. PubMed ID: 17372700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
    Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle.
    Hu L; Jia Y; Niu F; Jia Z; Yang X; Jiao K
    J Agric Food Chem; 2012 Jul; 60(29):7137-41. PubMed ID: 22587560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
    Singh B; Khurana L; Bandyopadhyay S; Kapil R; Katare OO
    Drug Deliv; 2011 Nov; 18(8):599-612. PubMed ID: 22008038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of fexofenadine microemulsions for intranasal delivery.
    Piao HM; Balakrishnan P; Cho HJ; Kim H; Kim YS; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2010 Aug; 395(1-2):309-16. PubMed ID: 20635476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization and in vivo evaluation of solid self-nanoemulsifying drug delivery system for oral administration of docetaxel.
    Quan Q; Kim DW; Marasini N; Kim DH; Kim JK; Kim JO; Yong CS; Choi HG
    J Microencapsul; 2013; 30(4):307-14. PubMed ID: 23101936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform.
    Choudhury H; Gorain B; Karmakar S; Biswas E; Dey G; Barik R; Mandal M; Pal TK
    Int J Pharm; 2014 Jan; 460(1-2):131-43. PubMed ID: 24239580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of bicyclol microemulsions for enhanced oral bioavailability.
    Ryu JK; Yoo SD
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1313-8. PubMed ID: 22283588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.